Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)

Saved in:

Bibliographic Details
Published in:	Europace (London, England) Vol. 20; no. 5; pp. 731 - 732an
Main Authors:	Dan, Gheorghe-Andrei, Martinez-Rubio, Antoni, Agewall, Stefan, Boriani, Giuseppe, Borggrefe, Martin, Gaita, Fiorenzo, van Gelder, Isabelle, Gorenek, Bulent, Kaski, Juan Carlos, Kjeldsen, Keld, Lip, Gregory Y H, Merkely, Bela, Okumura, Ken, Piccini, Jonathan P, Potpara, Tatjana, Poulsen, Birgitte Klindt, Saba, Magdi, Savelieva, Irina, Tamargo, Juan L, Wolpert, Christian, Sticherling, Christian, Ehrlich, Joachim R, Schilling, Richard, Pavlovic, Nikola, De Potter, Tom, Lubinski, Andrzej, Svendsen, Jesper Hastrup, Ching, Keong, Sapp, John Lewis, Chen-Scarabelli, Carol, Martinez, Felipe
Format:	Journal Article
Language:	English
Published:	England 01.05.2018
Subjects:	Anti-Arrhythmia Agents - pharmacology Arrhythmias, Cardiac - classification Arrhythmias, Cardiac - diagnosis Arrhythmias, Cardiac - drug therapy Clinical Decision-Making - methods Consensus Drug Monitoring - methods Drug-Related Side Effects and Adverse Reactions - prevention & control Humans Medication Therapy Management - standards
ISSN:	1099-5129, 1532-2092, 1532-2092
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!